Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(319)
•••
Post by Claridgeon Dec 04, 2019 9:33pm
162 Views
Post# 30423322

Destroying cancer at the speed of light

Destroying cancer at the speed of lightEnriquesSuave ... Nice catch.  Thanks for sharing.

Have you noticed that Theralase's trademark signature has evolved from "Healing at speed of light" (that was associated at with the therapeutic division to now "Destroying cancer at the speed of light" for its oncology division.

And notice the use of "destroying", instead of "shrinking"!

That shows another level of confidence. 

And what a brilliant way of distancing itself from the big pharma's traditional "pill" model and sending a clear message and making a bold statement to any newcomers, whether they are patients, oncologists, investors, medias, etc ... that a new era in standard treatment of care has arrived.



_______________________

enriquesuave - (12/4/2019 3:11:11 PM)
Twitter. Market research article
https://twitter.com/TheralaseTech/status/1202283748944994311

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities